Skip to main content

Premenstrual Syndrome

1
Pipeline Programs
5
Companies
5
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
1
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

4 companies ranked by most advanced pipeline stage

Human BioSciences
Human BioSciencesWV - Martinsburg
2 programs
1
sertralinePhase 41 trial
Krill oilN/A1 trial
Active Trials
NCT06584669Completed179Est. Aug 2013
NCT00318773Completed174Est. Feb 2008
City Therapeutics
City TherapeuticsMA - Cambridge
1 program
Auricular acupressure therapyN/A1 trial
Active Trials
NCT06981533CompletedEst. Jun 2025
Bayer
BayerLEVERKUSEN, Germany
1 program
Drospirenone and ethinyl estradiolN/A1 trial
Active Trials
NCT00633360Completed32Est. May 2011
Biomed
BiomedAustralia - Sydney
1 program
Shatavari Root ExtractN/A1 trial
Active Trials
NCT07441096Not Yet Recruiting60Est. Jul 2026

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Human BioSciencessertraline
BiomedShatavari Root Extract
City TherapeuticsAuricular acupressure therapy
Human BioSciencesKrill oil
BayerDrospirenone and ethinyl estradiol

Clinical Trials (5)

Total enrollment: 445 patients across 5 trials

NCT00318773Human BioSciencessertraline

Short-Term Versus Long-Term Treatment for Severe Premenstrual Syndrome (PMS)

Start: Feb 2002Est. completion: Feb 2008174 patients
Phase 4Completed
NCT07441096BiomedShatavari Root Extract

Efficacy and Safety of Shatavari Root Extract for Premenstrual Syndrome in Women

Start: Mar 2026Est. completion: Jul 202660 patients
N/ANot Yet Recruiting
NCT06981533City TherapeuticsAuricular acupressure therapy

Auricular Acupressure for Premenstrual Syndrome in Female Students

Start: Apr 2025Est. completion: Jun 2025
N/ACompleted
NCT06584669Human BioSciencesKrill oil

Investigation of Krill Oil in Women with Premenstrual Syndrome

Start: Feb 2012Est. completion: Aug 2013179 patients
N/ACompleted
NCT00633360BayerDrospirenone and ethinyl estradiol

The Oral Contraceptive Pill for Premenstrual Worsening of Depression

Start: Feb 2008Est. completion: May 201132 patients
N/ACompleted

Phase Legend

Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available

Key Insights

5 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.